Please Wait
Applying Filters...
menu
    • menu
    Capital Farma-PSE
    News
    Boehringer, Zealand's Obesity Drug Resembles Novo's Wegovy

    29 Apr 2026

    // BIOSPACE

    Emergent, Substipharm Partner on JE Vaccine Manufacturing

    29 Apr 2026

    // GLOBENEWSWIRE

    Revolution Issues Legal Threat to Erasca as Rivalry Heats

    29 Apr 2026

    // BIOSPACE

    DATA COMPILATION
    #PharmaFlow

    Capital Farma

    Contact Supplier

    Website

    CDMO Live Europe 2026

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.pharmacompass.com/video-pharmareel/capital-farma/we-are-a-global-company
    Menu

    Capital Farma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Alpha Phenylglycine

    02 1Alpha Phenylglycine

    03 2Tertiary Butylamine

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    Contact SupplierContact Supplier
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • Audit Compliance
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothCapital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Alpha Phenylglycine

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    2935-35-5
    Ampicillin
    Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharm...
    Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharmaceutical Ingredients (APIs) sourced from leading European manufacturers. The company co-develops proprietary APIs with established European Contract Manufacturing Organizations (CMOs) and offers complete product packages by combining APIs with Finished Dosage Form (FDF) dossiers. Capital Farma also supports market expansion through FDF licensing services, enabling partners to access new regions efficiently. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Capital Farma

    01

    Alpha Phenylglycine

    Spain
    CDMO Live Europe 2026
    Attending
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothCapital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.

    Capital Farma

    Alpha Phenylglycine

    CAS Number : 2935-35-5

    End Use API : Ampicillin

    About the Company : Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharmaceutical Ingredient...

    Capital Farma

    Intermediate Web Link

    Market Place

    Contact Supplier
    • Audit Compliance
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothCapital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Alpha Phenylglycine

    Intermediate Web Link

    Market Place

    2935-35-5
    Velpatasvir
    Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharm...
    Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharmaceutical Ingredients (APIs) sourced from leading European manufacturers. The company co-develops proprietary APIs with established European Contract Manufacturing Organizations (CMOs) and offers complete product packages by combining APIs with Finished Dosage Form (FDF) dossiers. Capital Farma also supports market expansion through FDF licensing services, enabling partners to access new regions efficiently. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Capital Farma

    02

    Alpha Phenylglycine

    Spain
    CDMO Live Europe 2026
    Attending
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothCapital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.

    Capital Farma

    Alpha Phenylglycine

    CAS Number : 2935-35-5

    End Use API : Velpatasvir

    About the Company : Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharmaceutical Ingredient...

    Capital Farma

    Intermediate Web Link

    Market Place

    Contact Supplier
    • Audit Compliance
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothCapital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Alpha Phenylglycine

    Intermediate Web Link

    Market Place

    2935-35-5
    Cephalexin
    Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharm...
    Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharmaceutical Ingredients (APIs) sourced from leading European manufacturers. The company co-develops proprietary APIs with established European Contract Manufacturing Organizations (CMOs) and offers complete product packages by combining APIs with Finished Dosage Form (FDF) dossiers. Capital Farma also supports market expansion through FDF licensing services, enabling partners to access new regions efficiently. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Capital Farma

    03

    Alpha Phenylglycine

    Spain
    CDMO Live Europe 2026
    Attending
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothCapital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.

    Capital Farma

    Alpha Phenylglycine

    CAS Number : 2935-35-5

    End Use API : Cephalexin

    About the Company : Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharmaceutical Ingredient...

    Capital Farma

    Intermediate Web Link

    Market Place

    Contact Supplier
    • Audit Compliance
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothCapital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Alpha Phenylglycine

    Intermediate Web Link

    Market Place

    2935-35-5
    Cephradine
    Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharm...
    Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharmaceutical Ingredients (APIs) sourced from leading European manufacturers. The company co-develops proprietary APIs with established European Contract Manufacturing Organizations (CMOs) and offers complete product packages by combining APIs with Finished Dosage Form (FDF) dossiers. Capital Farma also supports market expansion through FDF licensing services, enabling partners to access new regions efficiently. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Capital Farma

    04

    Alpha Phenylglycine

    Spain
    CDMO Live Europe 2026
    Attending
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothCapital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.

    Capital Farma

    Alpha Phenylglycine

    CAS Number : 2935-35-5

    End Use API : Cephradine

    About the Company : Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharmaceutical Ingredient...

    Capital Farma

    Intermediate Web Link

    Market Place

    Contact Supplier
    • Audit Compliance
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothCapital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Tertiary Butylamine

    Intermediate Web Link

    Market Place

    75-64-9
    Rifampicin
    Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharm...
    Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharmaceutical Ingredients (APIs) sourced from leading European manufacturers. The company co-develops proprietary APIs with established European Contract Manufacturing Organizations (CMOs) and offers complete product packages by combining APIs with Finished Dosage Form (FDF) dossiers. Capital Farma also supports market expansion through FDF licensing services, enabling partners to access new regions efficiently. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Capital Farma

    05

    Tertiary Butylamine

    Spain
    CDMO Live Europe 2026
    Attending
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothCapital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.

    Capital Farma

    Tertiary Butylamine

    CAS Number : 75-64-9

    End Use API : Rifampicin

    About the Company : Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharmaceutical Ingredient...

    Capital Farma

    Intermediate Web Link

    Market Place

    Contact Supplier
    • Audit Compliance
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothCapital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Tertiary Butylamine

    Intermediate Web Link

    Market Place

    75-64-9
    Perindopril
    Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharm...
    Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharmaceutical Ingredients (APIs) sourced from leading European manufacturers. The company co-develops proprietary APIs with established European Contract Manufacturing Organizations (CMOs) and offers complete product packages by combining APIs with Finished Dosage Form (FDF) dossiers. Capital Farma also supports market expansion through FDF licensing services, enabling partners to access new regions efficiently. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Capital Farma

    06

    Tertiary Butylamine

    Spain
    CDMO Live Europe 2026
    Attending
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothCapital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.

    Capital Farma

    Tertiary Butylamine

    CAS Number : 75-64-9

    End Use API : Perindopril

    About the Company : Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharmaceutical Ingredient...

    Capital Farma

    Intermediate Web Link

    Market Place

    Contact Capital Farma and get a quotation

    Capital Farma is a supplier offers 20 products (APIs, Excipients or Intermediates).

    Find Amidotrizoic Acid bulk offered by Capital Farma

    Find Bimatoprost bulk offered by Capital Farma

    Find Brinzolamide bulk offered by Capital Farma

    Find Clavulanic Acid bulk offered by Capital Farma

    Find Dienogest bulk offered by Capital Farma

    Find Drospirenone bulk offered by Capital Farma

    Find Etofenamate bulk offered by Capital Farma

    Find Fulvestrant bulk offered by Capital Farma

    Find Gadobutrol bulk offered by Capital Farma

    Find Galantamine Hydrobromide bulk offered by Capital Farma

    Find Hyoscine Butyl Bromide bulk offered by Capital Farma

    Find Latanoprost bulk offered by Capital Farma

    Find Minocycline Hydrochloride bulk offered by Capital Farma

    Find Nitazoxanide bulk offered by Capital Farma

    Find Nomegestrol Acetate bulk offered by Capital Farma

    Find Silodosin bulk offered by Capital Farma

    Find Silver Sulfadiazine bulk offered by Capital Farma

    Find Tafluprost bulk offered by Capital Farma

    Find Travoprost bulk offered by Capital Farma

    Find Trimebutine Maleate bulk offered by Capital Farma

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.